Business & Economy
Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis
Source: Business News · Published
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.
Related stories
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.
Business News ·
Paddy Power cuts 1,400 jobs and blames betting tax rises
The government increased taxes on online casino and sports betting in last year's Budget.
feeds.bbci.co.uk ·
Google Cloud problems: regulators push for details about outage which caused widespread disruption – latest updates
Google apologises after suffering a major Cloud outage in its London region today that caused problems at banks, Revolut, and court video cameras Google cloud failure hits millions as UK courts and banks knocked offline The pound has rallied after Britain’s unemployment rate fell
Business | The Guardian ·
General Motors beats Wall Street's Q3 earnings expectations, narrows full-year guidance
GM narrowed its 2026 earnings guidance and raised its adjusted automotive free cash flow outlook after beating Wall Street’s third-quarter estimates.
Business News ·
Best Buy launches new gaming hub ahead of 'Zelda' and 'Grand Theft Auto VI'
Best Buy is launching a new gaming experience for customers as it leans into the business ahead of this fall's big launches.
Business News ·